263 related articles for article (PubMed ID: 36634675)
1. RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia.
McMillan M; Gomez N; Hsieh C; Bekier M; Li X; Miguez R; Tank EMH; Barmada SJ
Mol Cell; 2023 Jan; 83(2):219-236.e7. PubMed ID: 36634675
[TBL] [Abstract][Full Text] [Related]
2. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia.
Archbold HC; Jackson KL; Arora A; Weskamp K; Tank EM; Li X; Miguez R; Dayton RD; Tamir S; Klein RL; Barmada SJ
Sci Rep; 2018 Mar; 8(1):4606. PubMed ID: 29545601
[TBL] [Abstract][Full Text] [Related]
3. TDP43 and RNA instability in amyotrophic lateral sclerosis.
Weskamp K; Barmada SJ
Brain Res; 2018 Aug; 1693(Pt A):67-74. PubMed ID: 29395044
[TBL] [Abstract][Full Text] [Related]
4. Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca
Markovinovic A; Martín-Guerrero SM; Mórotz GM; Salam S; Gomez-Suaga P; Paillusson S; Greig J; Lee Y; Mitchell JC; Noble W; Miller CCJ
Acta Neuropathol Commun; 2024 Feb; 12(1):32. PubMed ID: 38395965
[TBL] [Abstract][Full Text] [Related]
5. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1.
Barmada SJ; Ju S; Arjun A; Batarse A; Archbold HC; Peisach D; Li X; Zhang Y; Tank EM; Qiu H; Huang EJ; Ringe D; Petsko GA; Finkbeiner S
Proc Natl Acad Sci U S A; 2015 Jun; 112(25):7821-6. PubMed ID: 26056265
[TBL] [Abstract][Full Text] [Related]
7. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.
Barmada SJ; Serio A; Arjun A; Bilican B; Daub A; Ando DM; Tsvetkov A; Pleiss M; Li X; Peisach D; Shaw C; Chandran S; Finkbeiner S
Nat Chem Biol; 2014 Aug; 10(8):677-85. PubMed ID: 24974230
[TBL] [Abstract][Full Text] [Related]
8. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.
Cortese A; Plagnol V; Brady S; Simone R; Lashley T; Acevedo-Arozena A; de Silva R; Greensmith L; Holton J; Hanna MG; Fisher EM; Fratta P
Neurobiol Aging; 2014 Jun; 35(6):1491-8. PubMed ID: 24462217
[TBL] [Abstract][Full Text] [Related]
9. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.
Tziortzouda P; Van Den Bosch L; Hirth F
Nat Rev Neurosci; 2021 Apr; 22(4):197-208. PubMed ID: 33654312
[TBL] [Abstract][Full Text] [Related]
10. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
11. Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.
Weskamp K; Tank EM; Miguez R; McBride JP; Gómez NB; White M; Lin Z; Gonzalez CM; Serio A; Sreedharan J; Barmada SJ
J Clin Invest; 2020 Mar; 130(3):1139-1155. PubMed ID: 31714900
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
13. An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration.
Flores BN; Li X; Malik AM; Martinez J; Beg AA; Barmada SJ
Cell Rep; 2019 Apr; 27(4):1133-1150.e8. PubMed ID: 31018129
[TBL] [Abstract][Full Text] [Related]
14. TDP43 proteinopathy is associated with aberrant DNA methylation in human amyotrophic lateral sclerosis.
Appleby-Mallinder C; Schaber E; Kirby J; Shaw PJ; Cooper-Knock J; Heath PR; Highley JR
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):61-72. PubMed ID: 32365404
[TBL] [Abstract][Full Text] [Related]
15. TDP43 interacts with MLH1 and MSH6 proteins in a DNA damage-inducible manner.
Provasek VE; Kodavati M; Kim B; Mitra J; Hegde ML
Mol Brain; 2024 Jun; 17(1):32. PubMed ID: 38840222
[TBL] [Abstract][Full Text] [Related]
16. RNA/DNA Binding Protein TDP43 Regulates DNA Mismatch Repair Genes with Implications for Genome Stability.
Provasek VE; Bacolla A; Rangaswamy S; Mitra J; Kodavati M; Yusuf IO; Malojirao VH; Vasquez V; Britz GW; Li GM; Xu Z; Mitra S; Garruto RM; Tainer JA; Hegde ML
bioRxiv; 2024 May; ():. PubMed ID: 38798341
[TBL] [Abstract][Full Text] [Related]
17. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity.
Kitamura A; Nakayama Y; Shibasaki A; Taki A; Yuno S; Takeda K; Yahara M; Tanabe N; Kinjo M
Sci Rep; 2016 Jan; 6():19230. PubMed ID: 26757674
[TBL] [Abstract][Full Text] [Related]
18. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons.
Pozzi S; Codron P; Soucy G; Renaud L; Cordeau PJ; Dutta K; Bareil C; Julien JP
JCI Insight; 2020 Nov; 5(21):. PubMed ID: 33021970
[TBL] [Abstract][Full Text] [Related]
20. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
